← Back to Search

Other

External Device for Erectile Dysfunction (3D-Erect Trial)

N/A
Recruiting
Led By Michael Eisenberg, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and up to 1 month post-baseline
Awards & highlights

3D-Erect Trial Summary

This trial is testing a non-invasive 3D-printed external penile device to help men with ED have successful and satisfactory sexual intercourse.

Who is the study for?
This trial is for men over 18 with moderate to severe erectile dysfunction from various causes, such as post-prostate cancer treatment or vascular issues. Participants must have a female partner willing to be involved and must be open to trying sexual intercourse using the device.Check my eligibility
What is being tested?
The study is evaluating the safety and effectiveness of a non-invasive, 3D-printed external penile device designed to help men with erectile dysfunction achieve satisfactory sexual intercourse.See study design
What are the potential side effects?
Potential side effects are not specified in the provided information but may include discomfort or skin irritation related to wearing an external device.

3D-Erect Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and up to 1 month post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and up to 1 month post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in modified International Index of Erectile Dysfunction score

3D-Erect Trial Design

1Treatment groups
Experimental Treatment
Group I: 3D-Erect armExperimental Treatment1 Intervention
Participants will be asked to use the 3D-printed penile device during their intercourse with partners.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,346 Total Patients Enrolled
2 Trials studying Erectile Dysfunction
25 Patients Enrolled for Erectile Dysfunction
Michael Eisenberg, MDPrincipal InvestigatorStanford University
2 Previous Clinical Trials
26 Total Patients Enrolled
1 Trials studying Erectile Dysfunction
10 Patients Enrolled for Erectile Dysfunction

Media Library

3D-Erect (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04624126 — N/A
Erectile Dysfunction Research Study Groups: 3D-Erect arm
Erectile Dysfunction Clinical Trial 2023: 3D-Erect Highlights & Side Effects. Trial Name: NCT04624126 — N/A
3D-Erect (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04624126 — N/A
Erectile Dysfunction Patient Testimony for trial: Trial Name: NCT04624126 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are willing participants in this experiment?

"The listing on clinicaltrials.gov show that this research is currently looking for participants. The trial was originally posted on 7/10/2021, and as of 5/3/2022, the study is still active. 9 individuals are needed to enroll at 1 location."

Answered by AI

Are people still being allowed to sign up for this clinical trial?

"The data on clinicaltrials.gov show that this trial is still recruiting patients. The trial was originally posted on 7/10/2021 and was last updated on 5/3/2022. The study is looking for 9 patients at 1 site."

Answered by AI

Who else is applying?

What state do they live in?
California
Arizona
How old are they?
65+
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
What site did they apply to?
Stanford Health Care, Stanford Hospital
How many prior treatments have patients received?
3+
0

Why did patients apply to this trial?

I need the cash. I've tried a few ED medications with no success.
PatientReceived no prior treatments
~0 spots leftby Jun 2024